Pricing systems in US drug supply chain have many limitations; an analytics-based method might avoid some of them
Marianne Messer, Elsevier's Gold Standard
Advertisement
Articles by Marianne Messer, Elsevier's Gold Standard
Advertisement
Latest Updated Articles
- Analyzing drug-pricing mechanisms
Published: October 30th 2012 | Updated:
Advertisement
Advertisement
